Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) Marketable Securities: ¥13 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603882 Guangzhou Kingmed Diagnostics Group Co Ltd SHSE:603882
75 GF Score
Price ¥29.73
GF Value ¥28.19
Valuation Fairly Valued
! 11 Warning Signs
View Full Analysis

What is Guangzhou Kingmed Diagnostics Group Co Marketable Securities?

Guangzhou Kingmed Diagnostics Group Co SHSE:603882 -5.17% 75 Marketable Securities is ¥13 Mil as of Mar. 2026. GuruFocus rates SHSE:603882 with a GF Score™ of 75/100 and a GF Value™ of ¥28.19 (Fairly Valued). The stock has 11 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Guangzhou Kingmed Diagnostics Group Co's Marketable Securities for the quarter that ended in Mar. 2026 was ¥13 Mil.

Guangzhou Kingmed Diagnostics Group Co  (SHSE:603882) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Guangzhou Kingmed Diagnostics Group Co Marketable Securities Related Terms

Guangzhou Kingmed Diagnostics Group Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Guangzhou Kingmed Diagnostics Group Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangzhou Kingmed Diagnostics Group Co Marketable Securities Chart

Guangzhou Kingmed Diagnostics Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Guangzhou Kingmed Diagnostics Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 12.77
SHSE:603882
75GF Score
Guangzhou Kingmed Diagnostics Group Co Ltd SHSE:603882
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guangzhou Kingmed Diagnostics Group Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ¥13 Mil mean?
Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) has a Marketable Securities of ¥13 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Guangzhou Kingmed Diagnostics Group Co and its competitors.
Is Guangzhou Kingmed Diagnostics Group Co's Marketable Securities too high?
Guangzhou Kingmed Diagnostics Group Co's current Marketable Securities is ¥13 Mil. Overall, Guangzhou Kingmed Diagnostics Group Co has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Guangzhou Kingmed Diagnostics Group Co's Marketable Securities compare to TMO and DHR?
Guangzhou Kingmed Diagnostics Group Co's Marketable Securities of ¥13 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Diagnostics & Research company?
A good Marketable Securities depends on the Medical Diagnostics & Research industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Guangzhou Kingmed Diagnostics Group Co and its competitors. Guangzhou Kingmed Diagnostics Group Co's current Marketable Securities is ¥13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangzhou Kingmed Diagnostics Group Co stock overvalued right now?
Based on GuruFocus' analysis, Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) is currently considered Fairly Valued. The stock's GF Value™ is ¥28.19, compared to a current price of ¥29.73 — trading 5.5% above its estimated fair value. The current Marketable Securities is ¥13 Mil. Guangzhou Kingmed Diagnostics Group Co's overall GF Score™ is 75/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Guangzhou Kingmed Diagnostics Group Co (SHSE:603882), the current Marketable Securities is ¥13 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) Overvalued in 2026?

Based on GuruFocus' analysis, Guangzhou Kingmed Diagnostics Group Co stock appears to be overvalued. The current stock price of ¥29.73 is trading 5.5% above its estimated GF Value™ of ¥28.19. GuruFocus considers Guangzhou Kingmed Diagnostics Group Co to be Fairly Valued.

Key valuation signals for SHSE:603882:

  • Marketable Securities: ¥13 Mil
  • GF Value™: ¥28.19 vs. price of ¥29.73 (5.5% above fair value)
  • GF Score™: 75/100 with 11 warning signs

No single metric tells the full story. See the SHSE:603882 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guangzhou Kingmed Diagnostics Group Co Business Description

Address International Biological Island spiral three on the 10th, Guangdong Province, Guangzhou, CHN, 510000
Founded in 1994, KingMed is the largest independent clinical laboratory in China. It was listed on the Shanghai Stock Exchange in 2017. As of 2024, KingMed has 50 centralized labs and provides over 4000 test items. Over 90% of its total revenue comes from clinical diagnostics. Furthermore, KingMed has been actively investing in its cold chain logistics. Its service network covers the most intensely populated areas in China.
75GF Score

Get the complete analysis for SHSE:603882

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥29.73
Price
¥28.19
GF Value